ArticleJournal of translational medicine2015

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.

Carmela Rozera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.